Given the above, one can assume that carriers of PD-1.1*G allele could have a higher expression of PD-1 and in consequence inhibited activation and proliferation of T cells, which in turn can lead to poor ability to fight/remove cancer cells (41). The gene discussed is PDCD1; the disease is cancer.